Stock Markets Analysis & Opinion

Xylem Inc. (NYSE:XYL) is scheduled to release fourth-quarter 2019 results on Feb 6, before the market opens.The company witnessed weaker-than-expected results in one of the trailing four quarters...

ConocoPhillips (NYSE:COP) reported fourth-quarter 2019 adjusted earnings per share of 76 cents, missing the Zacks Consensus Estimate of 81 cents. Also, the bottom line declined from the year-ago...

Jacobs Engineering Group Inc. (NYSE:J) reported first-quarter fiscal 2020 (ended Dec 27, 2019) results, wherein earnings met the Zacks Consensus Estimate, while revenues beat the same. Meanwhile,...

Helmerich & Payne Inc. (NYSE:HP) recently released first-quarter fiscal 2020 results wherein it delivered a comprehensive earnings beat on the back of higher offshore rig margin and increase in...

Cummins Inc. (NYSE:CMI) reported earnings of $2.56 per share in fourth-quarter 2019, surpassing the Zacks Consensus Estimate of $2.42. Higher-than-expected contribution from the Components segment...

Eaton Corporation (NYSE:ETN) reported fourth-quarter 2019 earnings of $1.37 per share, which lagged the Zacks Consensus Estimate of $1.40 by 2.1%. The reported earnings were at the lower end of...

MetLife, Inc. (NYSE:MET) is set to release fourth-quarter and full-year 2019 earnings on Feb 5.In the last reported quarter, the company’s earnings missed the Zacks Consensus Estimate by 9.93%...

Investors are always looking for stocks that are poised to beat at earnings season and Merck & Co., Inc. (NYSE:MRK) may be one such company. The firm has earnings coming up pretty soon, and...

The key fourth-quarter technology stocks' earnings releases have painted a rosy picture so far, thanks to improving PC shipments, strengthening data center market, increasing proliferation of IoT and...

Tuesday, February 4, 2020An improvement in yesterday’s reported manufacturing data helped spur markets forward in regular trading, and market participants in today’s early morning trading...

Merck & Co. (NYSE:MRK) announced that the supplemental new drug application (sNDA) seeking approval of its new antibacterial injection Recarbrio for a new indication has been accepted by the...

NortonLifeLock, Inc. (NASDAQ:NLOK) is set to report third-quarter fiscal 2020 results on Feb 6.For the quarter, the company anticipates revenues between $602 million and $612 million (down 2% to...

Shares of Gilead Sciences, Inc. (NASDAQ:GILD) rose 5% after the company reported that its Remdesivir will undergo a trial for the CoronavirusShares of Maxar Technologies Inc. (TSX:MAXR) jumped...

We expect royalties from Innoviva, Inc.’s (NASDAQ:INVA) collaborated drugs to have driven revenues in fourth-quarter 2019.Shares of the company have lost 12.4% in the past...